| Views | |
|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 130 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 6 | 5 | 6 | 1 | 9 | 2 | 2 |
| Views | |
|---|---|
| Elagin_Correction.pdf | 66 |
| Views | |
|---|---|
| United States | 37 |
| Canada | 14 |
| Germany | 5 |
| Vietnam | 5 |
| Russia | 4 |
| Brazil | 2 |
| China | 2 |
| Czechia | 2 |
| Ecuador | 2 |
| Lithuania | 2 |
| Views | |
|---|---|
| Ottawa | 14 |
| Palo Alto | 4 |
| San Jose | 4 |
| Hanoi | 3 |
| San Francisco | 3 |
| Fairfield | 2 |
| Quito | 2 |
| Vilnius | 2 |
| Wilmington | 2 |
| Amsterdam | 1 |